Increased Skin Clearance and Quality of Life Improvement with Brodalumab Compared with Ustekinumab in Psoriasis Patients with Aggravating Lifestyle Factors.

Kokolakis, Georgios; Vadstrup, Kasper; Hansen, Jes B; Carrascosa, Jose Manuel

Kokolakis, Georgios; Vadstrup, Kasper; Hansen, Jes B; Carrascosa, Jose Manuel.

Afiliación

Kokolakis G; Clinic of Dermatology, Venereology and Allergology, Psoriasis Research and Treatment Centre, Charité-Universitätsmedizin Berlin, Luisenstrasse 2, 10117, Berlin, Germany. Georgios.kokolakis@charite.de.
Vadstrup K; LEO Pharma A/S, Industriparken 55, 2750, Ballerup, Denmark.
Hansen JB; LEO Pharma A/S, Industriparken 55, 2750, Ballerup, Denmark.
Carrascosa JM; Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma of Barcelona, IGTP, Carretera de Canyet, s/n, 08916, Badalona, Barcelona, Spain.

Dermatol Ther (Heidelb) ; 11(6): 2027-2042, 2021 Dec.

Article en En | MEDLINE | ID: mdl-34606048

Palabras clave

Alcohol consumption; Brodalumab; Obesity; Psoriasis; QoL; Skin clearance; Smoking; Ustekinumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Dermatol Ther (Heidelb) Año: 2021 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google